Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Gliosarcoma 4 Glioma 4 Glioblastoma 4 Ganglioneuroblastoma 4 Pancreatic Neoplasms 3 Neuroblastoma 3 Vaginal Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oligodendroglioma 2 Lung Neoplasms 2 Glioma, Subependymal 2 Ependymoma 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Astrocytoma 2 Adenocarcinoma Of Esophagus 2 Wilms Tumor 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Thoracic Diseases 1

Interventions

Indocyanine Green 7 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Lymph Node Excision 4 Cisplatin 4 Surgical Procedures, Operative 3 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 gadofosveset trisodium 2 Technetium 2 TP protocol 2 Sentinel Lymph Node Biopsy 2 Radiation Dose Hypofractionation 2 Nivolumab 2 Ipilimumab 2 Electroporation 2 Conversion to Open Surgery 2 Control Groups 2 tislelizumab 1 radium Ra 223 dichloride 1 peposertib 1 pembrolizumab 1 gewf solution 1 encorafenib 1 cabozantinib 1 binimetinib 1 avelumab 1 alovudine 1 X-Rays 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphatic Metastasis × Congresses as Topic × Clear all

NCT05867095 2023-05-19

N16LND

The Netherlands Cancer Institute

Phase NA Completed

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡